Page last updated: 2024-11-04

sarpogrelate and Non-alcoholic Fatty Liver Disease

sarpogrelate has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

sarpogrelate: structure given in first source

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"Nonalcoholic fatty liver disease (NAFLD) is increasing in worldwide prevalence, closely tracking the obesity epidemic, but specific pharmaceutical treatments for NAFLD are lacking."1.48Serotonin signals through a gut-liver axis to regulate hepatic steatosis. ( Bang, G; Choi, C; Choi, W; Han, KH; Hwang, I; Jeong, JS; Ju, YS; Karsenty, G; Kim, H; Kim, YH; Lee, HW; Lim, A; Namkung, J; Park, HJ; Park, JY; Park, S; Suh, JM; Yadav, VK, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, W1
Namkung, J1
Hwang, I1
Kim, H2
Lim, A1
Park, HJ1
Lee, HW1
Han, KH1
Park, S2
Jeong, JS1
Bang, G1
Kim, YH1
Yadav, VK1
Karsenty, G1
Ju, YS1
Choi, C1
Suh, JM1
Park, JY1

Other Studies

1 other study available for sarpogrelate and Non-alcoholic Fatty Liver Disease

ArticleYear
Serotonin signals through a gut-liver axis to regulate hepatic steatosis.
    Nature communications, 2018, 11-16, Volume: 9, Issue:1

    Topics: Animals; Diet, High-Fat; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulati

2018